Celldex Therapeutics Stock Forecast
Celldex Therapeutics stock downgraded to Sell Candidate
(Updated on Apr 25, 2024)
The Celldex Therapeutics stock price fell by -2.05% on the last day (Thursday, 25th Apr 2024) from $37.02 to $36.26. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.61% from a day low at $35.86 to a day high of $37.16. The price has fallen in 8 of the last 10 days and is down by -11.28% for this period. Volume has increased on the last day by 671 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $36.95 million.
Given the current short-term trend, the stock is expected to rise 2.52% during the next 3 months and, with a 90% probability hold a price between $37.18 and $54.00 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CLDX Signals & Forecast
There are few to no technical positive signals at the moment. The Celldex Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $38.01 and $41.02. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -30.11%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Celldex Therapeutics stock
Celldex Therapeutics finds support from accumulated volume at $35.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.30 between high and low, or 3.61%. For the last week, the stock has had daily average volatility of 3.98%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CLDX) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Celldex Therapeutics to open at $36.43, and during the day (based on 14 day Average True Range), to move between $34.53 and $37.99, which gives a possible trading interval of +/-$1.73 (+/-4.78%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 9.57% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $35.54 (1.99%) than the resistance at $37.75 (4.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Celldex Therapeutics will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.670. We will update the financials statements for Celldex Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.24% in the first trading day after earnings release.
Is Celldex Therapeutics stock A Buy?
The Celldex Therapeutics stock holds several negative signals and despite the positive trend, we believe Celldex Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -2.505 Sell Candidate Downgraded
Predicted Opening Price for Celldex Therapeutics of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $36.43 ( 0.455%) | $36.26 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CLDX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 37.72 | 4.03 % | |
| R2 | 37.23 | 2.66 % | ||
| R1 | 36.92 | 1.82 % | ||
| Current price: | 36.26 | |||
| Support | S1 | 35.93 | -0.91 % | |
| S2 | 35.62 | -1.75 % | ||
| S3 | 35.13 | -3.12 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 42.01 | 15.86 % | |
| R2 | 38.25 | 5.49 % | ||
| R1 | 37.75 | 4.11 % | ||
| Current price | 36.26 | |||
| Support | S1 | 35.54 | -1.99% | |
| S2 | 35.50 | -2.10% | ||
| S3 | 35.22 | -2.87% |
FAQ
Click here for our free guide on how to buy Celldex Therapeutics Stock.
